Related Experiment Video
Updated: May 19, 2026
Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
Regenerating cardiac cells: insights from the bench and the clinic
Miao Teng1, XiaoHui Zhao, YueSheng Huang
1Institute of Burn Research, State Key Laboratory of Trauma, Burns and Combined Injury, Southwest Hospital, The Third Military Medical University, Chongqing, 400038, China.
Insights
Discovering cardiac stem cells offers new hope for heart repair. Understanding these cells is key to advancing regenerative medicine for treating heart disease.
Area of Science:
- Cardiovascular regenerative medicine
- Cardiac stem cell biology
Background:
- The adult mammalian heart contains cardiac stem and progenitor cells, challenging the notion of its limited regenerative potential.
- The origin of diverse adult cardiac stem/progenitor cell types remains unclear.
Purpose of the Study:
- To review current knowledge on discovered adult cardiac stem and progenitor cell types.
- To summarize ongoing clinical trials using adult stem cells for myocardial repair in coronary artery disease patients.
Main Methods:
- Literature review of scientific publications on cardiac stem and progenitor cells.
- Analysis of data from ongoing clinical trials involving adult stem cell therapy for heart repair.
Main Results:
- Multiple types of adult cardiac stem and progenitor cells have been identified.
- Clinical trials are actively investigating the efficacy of these cells in repairing damaged heart muscle.
Conclusions:
- Further understanding of cardiac stem and progenitor cell physiology is crucial for successful regenerative therapies.
- Adult stem cell therapies show promise for treating heart disease, with ongoing clinical evaluation.
Abstract:
A major challenge in cardiovascular regenerative medicine is the development of novel therapeutic strategies to restore the function of cardiac muscle in the failing heart. The heart has historically been regarded as a terminally differentiated organ that does not have the potential to regenerate. This concept has been updated by the discovery of cardiac stem and progenitor cells that reside in the adult mammalian heart. Whereas diverse types of adult cardiac stem or progenitor cells have been described, we still do not know whether these cells share a common origin. A better understanding of the physiology of cardiac stem and progenitor cells should advance the successful use of regenerative medicine as a viable therapy for heart disease. In this review, we summarize current knowledge of the various adult cardiac stem and progenitor cell types that have been discovered. We also review clinical trials presently being undertaken with adult stem cells to repair the injured myocardium in patients with coronary artery disease.
